text_1: AMP-activated protein kinase (AMPK) activation reduces inflammation-related fibrosis in the lungs.
text_2: Pharmacological activation of AMPK in myofibroblasts from lungs of humans with IPF display lower fibrotic activity, along with enhanced mitochondrial biogenesis and normalization of sensitivity to apoptosis.